Compare BOTJ & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOTJ | BDSX |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 62.5M |
| IPO Year | N/A | 2020 |
| Metric | BOTJ | BDSX |
|---|---|---|
| Price | $18.31 | $6.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | 4.1K | ★ 66.3K |
| Earning Date | 01-30-2026 | 11-03-2025 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.74 | N/A |
| Revenue | $47,669,000.00 | ★ $80,173,000.00 |
| Revenue This Year | N/A | $20.75 |
| Revenue Next Year | N/A | $25.05 |
| P/E Ratio | $10.41 | ★ N/A |
| Revenue Growth | 8.53 | ★ 22.29 |
| 52 Week Low | $11.56 | $3.44 |
| 52 Week High | $18.75 | $31.40 |
| Indicator | BOTJ | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 41.04 |
| Support Level | $17.75 | $6.30 |
| Resistance Level | $18.75 | $8.03 |
| Average True Range (ATR) | 0.37 | 0.66 |
| MACD | -0.05 | -0.18 |
| Stochastic Oscillator | 26.81 | 17.36 |
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.